Cargando…

Septin 9 isoform expression, localization and epigenetic changes during human and mouse breast cancer progression

INTRODUCTION: Altered expression of Septin 9 (SEPT9), a septin coding for multiple isoform variants, has been observed in several carcinomas, including colorectal, head and neck, ovarian and breast, compared to normal tissues. The mechanisms regulating its expression during tumor initiation and prog...

Descripción completa

Detalles Bibliográficos
Autores principales: Connolly, Diana, Yang, Zhixia, Castaldi, Maria, Simmons, Nichelle, Oktay, Maja H, Coniglio, Salvatore, Fazzari, Melissa J, Verdier-Pinard, Pascal, Montagna, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236340/
https://www.ncbi.nlm.nih.gov/pubmed/21831286
http://dx.doi.org/10.1186/bcr2924
_version_ 1782218723751362560
author Connolly, Diana
Yang, Zhixia
Castaldi, Maria
Simmons, Nichelle
Oktay, Maja H
Coniglio, Salvatore
Fazzari, Melissa J
Verdier-Pinard, Pascal
Montagna, Cristina
author_facet Connolly, Diana
Yang, Zhixia
Castaldi, Maria
Simmons, Nichelle
Oktay, Maja H
Coniglio, Salvatore
Fazzari, Melissa J
Verdier-Pinard, Pascal
Montagna, Cristina
author_sort Connolly, Diana
collection PubMed
description INTRODUCTION: Altered expression of Septin 9 (SEPT9), a septin coding for multiple isoform variants, has been observed in several carcinomas, including colorectal, head and neck, ovarian and breast, compared to normal tissues. The mechanisms regulating its expression during tumor initiation and progression in vivo and the oncogenic function of its different isoforms remain elusive. METHODS: Using an integrative approach, we investigated SEPT9 at the genetic, epigenetic, mRNA and protein levels in breast cancer. We analyzed a panel of breast cancer cell lines, human primary tumors and corresponding tumor-free areas, normal breast tissues from reduction mammoplasty patients, as well as primary mammary gland adenocarcinomas derived from the polyoma virus middle T antigen, or PyMT, mouse model. MCF7 clones expressing individual GFP-tagged SEPT9 isoforms were used to determine their respective intracellular distributions and effects on cell migration. RESULTS: An overall increase in gene amplification and altered expression of SEPT9 were observed during breast tumorigenesis. We identified an intragenic alternative promoter at which methylation regulates SEPT9_v3 expression. Transfection of specific GFP-SEPT9 isoforms in MCF7 cells indicates that these isoforms exhibit differential localization and affect migration rates. Additionally, the loss of an uncharacterized SEPT9 nucleolar localization is observed during tumorigenesis. CONCLUSIONS: In this study, we found conserved in vivo changes of SEPT9 gene amplification and overexpression during human and mouse breast tumorigenesis. We show that DNA methylation is a prominent mechanism responsible for regulating differential SEPT9 isoform expression and that breast tumor samples exhibit distinctive SEPT9 intracellular localization. Together, these findings support the significance of SEPT9 as a promising tool in breast cancer detection and further emphasize the importance of analyzing and targeting SEPT9 isoform-specific expression and function.
format Online
Article
Text
id pubmed-3236340
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32363402011-12-14 Septin 9 isoform expression, localization and epigenetic changes during human and mouse breast cancer progression Connolly, Diana Yang, Zhixia Castaldi, Maria Simmons, Nichelle Oktay, Maja H Coniglio, Salvatore Fazzari, Melissa J Verdier-Pinard, Pascal Montagna, Cristina Breast Cancer Res Research Article INTRODUCTION: Altered expression of Septin 9 (SEPT9), a septin coding for multiple isoform variants, has been observed in several carcinomas, including colorectal, head and neck, ovarian and breast, compared to normal tissues. The mechanisms regulating its expression during tumor initiation and progression in vivo and the oncogenic function of its different isoforms remain elusive. METHODS: Using an integrative approach, we investigated SEPT9 at the genetic, epigenetic, mRNA and protein levels in breast cancer. We analyzed a panel of breast cancer cell lines, human primary tumors and corresponding tumor-free areas, normal breast tissues from reduction mammoplasty patients, as well as primary mammary gland adenocarcinomas derived from the polyoma virus middle T antigen, or PyMT, mouse model. MCF7 clones expressing individual GFP-tagged SEPT9 isoforms were used to determine their respective intracellular distributions and effects on cell migration. RESULTS: An overall increase in gene amplification and altered expression of SEPT9 were observed during breast tumorigenesis. We identified an intragenic alternative promoter at which methylation regulates SEPT9_v3 expression. Transfection of specific GFP-SEPT9 isoforms in MCF7 cells indicates that these isoforms exhibit differential localization and affect migration rates. Additionally, the loss of an uncharacterized SEPT9 nucleolar localization is observed during tumorigenesis. CONCLUSIONS: In this study, we found conserved in vivo changes of SEPT9 gene amplification and overexpression during human and mouse breast tumorigenesis. We show that DNA methylation is a prominent mechanism responsible for regulating differential SEPT9 isoform expression and that breast tumor samples exhibit distinctive SEPT9 intracellular localization. Together, these findings support the significance of SEPT9 as a promising tool in breast cancer detection and further emphasize the importance of analyzing and targeting SEPT9 isoform-specific expression and function. BioMed Central 2011 2011-08-10 /pmc/articles/PMC3236340/ /pubmed/21831286 http://dx.doi.org/10.1186/bcr2924 Text en Copyright ©2011 Connolly et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Connolly, Diana
Yang, Zhixia
Castaldi, Maria
Simmons, Nichelle
Oktay, Maja H
Coniglio, Salvatore
Fazzari, Melissa J
Verdier-Pinard, Pascal
Montagna, Cristina
Septin 9 isoform expression, localization and epigenetic changes during human and mouse breast cancer progression
title Septin 9 isoform expression, localization and epigenetic changes during human and mouse breast cancer progression
title_full Septin 9 isoform expression, localization and epigenetic changes during human and mouse breast cancer progression
title_fullStr Septin 9 isoform expression, localization and epigenetic changes during human and mouse breast cancer progression
title_full_unstemmed Septin 9 isoform expression, localization and epigenetic changes during human and mouse breast cancer progression
title_short Septin 9 isoform expression, localization and epigenetic changes during human and mouse breast cancer progression
title_sort septin 9 isoform expression, localization and epigenetic changes during human and mouse breast cancer progression
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236340/
https://www.ncbi.nlm.nih.gov/pubmed/21831286
http://dx.doi.org/10.1186/bcr2924
work_keys_str_mv AT connollydiana septin9isoformexpressionlocalizationandepigeneticchangesduringhumanandmousebreastcancerprogression
AT yangzhixia septin9isoformexpressionlocalizationandepigeneticchangesduringhumanandmousebreastcancerprogression
AT castaldimaria septin9isoformexpressionlocalizationandepigeneticchangesduringhumanandmousebreastcancerprogression
AT simmonsnichelle septin9isoformexpressionlocalizationandepigeneticchangesduringhumanandmousebreastcancerprogression
AT oktaymajah septin9isoformexpressionlocalizationandepigeneticchangesduringhumanandmousebreastcancerprogression
AT conigliosalvatore septin9isoformexpressionlocalizationandepigeneticchangesduringhumanandmousebreastcancerprogression
AT fazzarimelissaj septin9isoformexpressionlocalizationandepigeneticchangesduringhumanandmousebreastcancerprogression
AT verdierpinardpascal septin9isoformexpressionlocalizationandepigeneticchangesduringhumanandmousebreastcancerprogression
AT montagnacristina septin9isoformexpressionlocalizationandepigeneticchangesduringhumanandmousebreastcancerprogression